HUAREN MEDICAL TECHNOLOGY
NEWS
27
2022-03
Vigilance! Senescent Immune Cells Age Bones
The human skeleton undergoes a continuous remodelling process throughout adulthood to repair small cracks that keep appearing. This remodelling process is precisely balanced between osteoblastic bone formation and osteoclastic bone resorption. However, with age, this homeostasis is markedly compromised in terms of reduced bone remodelling and accumulation of bone marrow fat, which in turn can lead to bone fragility, particularly as bone marrow mesenchymal stem cells (BMSCs), the sole cellular source of osteoblasts, are prone to fat formation rather than bone formation during ageing. Current research suggests that this is caused by mediators in the bone marrow microenvironment, whose primary function is to support and regulate the skeletal function of various cell types, including haematopoietic and mesenchymal cells, in order to maintain homeostasis in the body.
View More18
2022-03
On March 17, 2022, Fan Jojun, vice president of Guangxi University, led the development planning office, science and technology office, medical school and other units of the relevant responsible person and teachers, went to the Guangxi Academy of Sciences Institute of Medicine and Health, Huaren Medical Science and Technology Group Joint Experimental Center to carry out research on industry-university-research cooperation, and the President of the College, Ji Feng, and others accompanied the whole process.
View More12
2022-03
On March 11, 2022, the awarding ceremony of the Institute of Medicine and Health of Guangxi Academy of Sciences and the launching conference of the Joint Experimental Center of Huaren Medical Science and Technology Group were successfully held. Yuan Chang'an, secretary of the party group and president of Guangxi Academy of Sciences, and Ji Feng, president of the Institute of Medicine and Health of Guangxi Academy of Sciences, delivered speeches. Relevant leaders and staff from Guangxi University, Guangxi University of Traditional Chinese Medicine, Guangxi Medical University, Guangxi Physicians Association, Nanning Normal University, Jiangnan District Government, Liangqing District Government, Guangxi Nongken Group, Nanning Municipal Health Commission, Nanning Municipal Customs Technology Center and other departments attended the ceremony. Ltd., Guangxi Xiongsen Primate Breeding and Development Co., Ltd. and Guangzhou Jisai Regenerative Medicine Life Science and Technology Co.
View More05
2022-03
From March 1 to March 2, 2022, Shi Weidong, Vice President of Zhoukou Hospital of Traditional Chinese Medicine in Henan Province, and his three-member delegation visited Guangxi Academy of Sciences Institute of Medicine and Health to investigate and negotiate opportunities for cooperation in terms of technological innovation, platform establishment, project cooperation, and transformation of achievements.
View More05
2022-03
SUMOylation is a reversible post-translational modification associated with cancer. Many post-translational modifications occur on proteins, mainly controlling protein function, localisation and stability, and regulation of proteins by reversible post-translational modifications, such as phosphorylation and ubiquitination, enhances cellular response to stress. Numerous proteomics studies have revealed differences in post-translational modifications between healthy and tumour tissues: phosphorylation and ubiquitination are abnormally elevated in a wide range of cancers, and many protein kinase inhibitors as well as inhibitors of the ubiquitination pathway have been clinically used for the treatment of different types of tumours; however, their specificity is still a major obstacle to cancer therapy.
View More26
2022-02
The Winter Olympics closed successfully, and during this Winter Olympics there was an extremely widely participated discussion: should you get enough 10 hours of sleep every night? It sparked a hot debate about sleep on social networks. How do you understand this whole sleep thing from a medical and genetic point of view?
View More